Boston Scientific Corp Stock Alpha and Beta Analysis
| BSX Stock | USD 84.73 0.37 0.43% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Boston Scientific Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Boston Scientific over a specified time horizon. Remember, high Boston Scientific's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Boston Scientific's market risk premium analysis include:
Beta 0.58 | Alpha 0.0827 | Risk 0.96 | Sharpe Ratio 0.2 | Expected Return 0.19 |
Boston Scientific Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Boston |
Boston Scientific Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Boston Scientific market risk premium is the additional return an investor will receive from holding Boston Scientific long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Boston Scientific. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Boston Scientific's performance over market.| α | 0.08 | β | 0.58 |
Boston Scientific expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Boston Scientific's Buy-and-hold return. Our buy-and-hold chart shows how Boston Scientific performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Boston Scientific Market Price Analysis
Market price analysis indicators help investors to evaluate how Boston Scientific stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Boston Scientific shares will generate the highest return on investment. By understating and applying Boston Scientific stock market price indicators, traders can identify Boston Scientific position entry and exit signals to maximize returns.
Boston Scientific Return and Market Media
The median price of Boston Scientific for the period between Sat, Jul 27, 2024 and Fri, Oct 25, 2024 is 82.57 with a coefficient of variation of 5.4. The daily time series for the period is distributed with a sample standard deviation of 4.39, arithmetic mean of 81.26, and mean deviation of 3.75. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 1197 shares by Wendy Carruthers of Boston Scientific at 24.55 subject to Rule 16b-3 | 09/13/2024 |
2 | Boston Scientific Corporation Gains 44 percent YTD as Farapulse Launch Drives 17 percent Q2 Growth | 09/30/2024 |
3 | Electrophysiology Market is expected to generate a revenue of USD 17.04 Billion by 2031, Globally, at 9.62 percent CAGR Verified Market Research | 10/08/2024 |
4 | JJ, Abbott and Intuitive kick off latest medtech earnings season | 10/14/2024 |
5 | Heres How Much a 1000 Investment in Boston Scientific Made 10 Years Ago Would Be Worth Today | 10/16/2024 |
6 | ResMed Earnings Expected to Grow Should You Buy | 10/17/2024 |
7 | Electrophysiology Market is expected to generate a revenue of USD 13.29 Billion by 2031, Globally, at 11.47 percent CAGR Verified Market Research | 10/18/2024 |
8 | Boston Scientific wins FDA approval for Farapulse cardiac mapping | 10/21/2024 |
9 | Boston Scientific Q3 Earnings Preview | 10/22/2024 |
10 | Zai Lab, A Top 6 percent Stock, Launched To A 16-Month High On Its Impressive Results | 10/24/2024 |
About Boston Scientific Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Boston or other stocks. Alpha measures the amount that position in Boston Scientific Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 9.1E-4 | 8.31E-4 | 3.33E-4 | 3.17E-4 | Price To Sales Ratio | 5.08 | 5.22 | 5.9 | 4.58 |
Boston Scientific Upcoming Company Events
As portrayed in its financial statements, the presentation of Boston Scientific's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Boston Scientific's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Boston Scientific's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Boston Scientific. Please utilize our Beneish M Score to check the likelihood of Boston Scientific's management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Boston Scientific
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.